Cycloporin 2mg/kg/d vs 4mg/kg/d in ASUC
Epidermal Growth Factor Enemas in left side UC
Natalizumab in CD
Oral tacrolimus in fistulizing CD
Hydrocortisone IV and anti drug antibody formation
5ASA in CD for postop recurrence
NOD2/CARD15 gene polymorphisms and CD in the Chinese population
Appendectomy is followed by increased risk of Crohn’s disease
Smoking and UC risk (case-control. Australia)